Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Mar 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$48K
Net Open-Market Flow
-$48K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2025Sell(S)2K$12.31$25K2.8M
Mar 13, 2025Sell(S)2K$11.80$24K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-009017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML